The Lancet, a peer-reviewed medical journal that published a 96,000-subject study indicting the efficacy of the politically controversial hydroxychloroquine for COVID-19 has retracted its findings that the malaria medication led to an increased risk of death.
“Today, three of the authors of the paper, ‘Hydroxychloroquine or
chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis”, have retracted their study,” The
Lancet said in a retraction statement Thursday. “They were unable to complete an independent audit of the
data underpinning their analysis. As a result, they have concluded that they ‘can no longer vouch for the veracity of the primary data sources.”
“We deeply apologise to you, the editors, and the journal readership for any embarrassment or inconvenience that this may have caused,” the authors of the study wrote.
In an important moment for science and data transparency, @thelancet announces that its 96,000 observational study on hydroxychloroquine has been RETRACTED.
— Jeremy Faust MD MS (@jeremyfaust) June 4, 2020
The study was first published in May and was the largest ever conducted analyzing the impacts of hydroxychloroquine after President Donald Trump was reported to be taking the medication as a precautionary measure following possible exposure to the virus.
Legacy media meanwhile, with its animus for Trump, used the study to attack the president and his physician for taking a medication that had anecdotally shown potential promise in treatment of infection while
posing few risks. Trump had previously touted the possible benefits of the medication approved by the Food and Drug Administration for emergency use during press
briefings to reporters who pinned the death of an uninfected man who
drank fish tank cleaner outside of medical guidance on the president.